The purpose of this randomized, open-label study was to assess the efficacy of the product Interceed absorbable adhesion barrier in the prevention of adhesion formation on the ovary after laparoscopic ovarian cystectomy. A total of 25 patients requiring laparoscopic bilateral ovarian cystectomy were enrolled into this study. After removal of ovarian cysts, peri-adnexal adhesions, and peritoneal irrigants, and the attainment of meticulous haemostasis, the random assignment of one ovary for wrapping with Interceed was revealed to the surgeon. The other ovary served as the untreated control. A follow-up laparoscopy was performed 8-30 weeks after the initial procedure in 17 patients. Significantly fewer adhesions formed at the Interceed treated ovaries compared with the control (untreated) ovaries (P < 0.05). In terms of adhesion-free outcome, 76% (13/17) of Interceed treated ovaries and 35% (6/17) of control ovaries were free of adhesions. A significant reduction was observed in the area of the sutured ovaries involved with adhesions when Interceed (6%) was used, compared with controls (20%). The reduction of adhesion formation was not related to the size of the cysts at the initial procedure. No adverse events were reported by any patient during the study. In conclusion, Interceed was found to be safe and effective in reducing the incidence of postoperative adhesion formation in patients undergoing laparoscopic ovarian cystectomy.
Introduction
Although it is widely recognized that the product Interceed absorbable adhesion barrier reduces adhesions to the pelvic sidewall following gynaecological surgery (Sekiba et al, 1992;  •This work has been presented in part at the XTV World Congress of Gynaecology and Obstetrics (FIGO), Montreal, Canada, September 1994.
© European Society for Human Reproduction and Embryology Azziz et al, 1993; Li and Cooke, 1994) , only recently have studies been available which specifically address prevention of adhesions on the ovary (Franklin et al, 1995; Nordic Adhesion Prevention Study Group, 1995) . This is of particular interest not only because the ovary is primarily involved in reproductive function and post-surgical pain (Steege and Stout, 1991; Howard, 1993; Steege et al, 1993; Oelsner et al, 1994) , but also because the ovary is the most common site for adhesion formation (Diamond et al, 1987) . Recently, Van Geldorp (1994) , and Franklin et al. (1995) have reported that wrapping of the ovary with Interceed significantly reduced adhesion formation after ovarian cystectomy and/or ovariolysis.
However, in all of these studies, wrapping of the ovary with Interceed occurred at the end of a laparotomy procedure. In general practice, this type of surgical therapy of the ovary is often administered via laparoscopy. In the present study, we evaluated the efficacy of Interceed placement around the ovary after laparoscopic surgery for the removal of ovarian cysts.
Materials and methods
This was a prospective, randomized, open-label study performed at the University of Ulm, Germany, between 1990 and . A group of 25 females requiring bilateral ovarian cystectomy were enrolled. A follow-up laparoscopy was part of the planned treatment All patients were at least 18 years of age, had a uterus, and bilateral Fallopian tubes and ovaries. Patients found to have severe adhesions in the pelvis upon the initial procedure were excluded, as such adhesions may have confounded the study objective of examining adhesion formation after ovarian cystectomy rather than after adhesiolysis. Patients who had undergone previous laparoscopic surgery, pregnant patients, patients with cancer and those receiving any type of anti-cancer therapy, were also excluded.
Patients gave consent to be enrolled in the study prior to their first laparoscopy during which some, as stated above, were excluded if dense adhesions were present Both the initial surgical procedure including placement of Interceed, as well as the follow-up secondlook procedure, were performed exclusively by laparoscopy.
Bilateral ovarian cystectomies were performed at the time of the initial surgical procedure. In addition, all endometriosis, adnexal and uterine adhesions were removed Each ovary was examined and the percentage of the ovarian surface involved with adhesions was estimated The severity of ovarian adhesions was classified as either filmy, vascular or dense. The number, size (diameter) and type of cysts on each ovary were noted Concerning histological entities, each cyst was scored as if it were on a separate ovary if the ovary contained more than one cyst In regard to adhesions, however, scoring was performed per ovary no matter how many cysts it bore.
Haemostasis was achieved using either bipolar or monopolar electrocoagulation or an argon beam coagulator. When indicated, the ovarian defects were closed with 2-0 or 4-0 polydioxanon (PDS) sutures (Ethicon, Norderstedt, Germany) using intra-or extra-corporeal knot tying. At the end of cystectomy the random assignment of one ovary for wrapping with Interceed (Johnson & Johnson Medical GmbH, Norderstedt, Germany) was revealed to the surgeon after a coin toss. After haemostasis was achieved and peritoneal irrigants were removed, one-half to one piece of the 10X7.5 cm size of Interceed was used to wrap an ovary completely. The ovary was lifted by a probe while the Interceed was directed onto the ovarian fossa. The ovary was then returned to its normal anatomical location, the other end of the Interceed was brought over the anterior surface of the ovary and moistened with a few millilitres of irrigant, usually Ringer's lactate. Inspection was performed to ensure that the Interceed did not turn black, indicative of inadequate haemostasis. All black Interceed barriers were removed, haemostasis was re-established, and a new piece of Interceed was used to re-wrap the ovary.
The contralateral ovary was the control. Treatment was the same except no Interceed was used. Corticosteroids, non-steroidal anti-inflammatory drugs, and peritoneal instillates including Hyskon (Pharmacia, Uppsala, Sweden) were not used.
The presence, extent and severity of adhesions were assessed at second-look laparoscopy 8-30 weeks after initial surgery. Although questions regarding the reliability of such an assessment arose, the intra-and inter-observer variabilities seemed to be acceptable (Bowman et aL, 1995; Corson et al., 1995) . Comparisons were made between ovaries treated with Interceed and those that were not, using a x^test or Fisher's exact test. Comparisons were also made of adhesion formation between sutured and non-sutured ovaries using Student's /-test.
Only those patients returning for a second-look procedure were included in the efficacy analysis. All the patients were included in the safety analysis.
Results
All 25 patients underwent the initial surgical procedure without any complications. Seventeen out of these patients (68%) returned for second-look laparoscopy. Table I displays profiles on the size and occurrence of cysts in patients with and without endometriomas. At the initial laparoscopic procedure, 16 cysts (five mucinous, 11 serous) and 22 endometriomas were found. They were equally distributed between the Interceed treated and the control ovaries.
The incidence of adhesions on each ovary was evaluated at second-look laparoscopy. Of the 17 Interceed treated ovaries, 13 (76%) were free of adhesions, whereas only six of the 17 control ovaries (35%) were adhesion-free (Figure 1 ). This difference was statistically significant (x 2 = 4.295; P < 0.05). The adhesions that did form were all filmy in their consistency, none was dense or vascular (Table II) . Five of the eight Interceed treated ovaries which had endometriomas were adhesion-free at second-look laparoscopy (62.5%) compared with four out of 11 control ovaries (36%). Although this difference was similar to that observed in the whole study population, it was not statistically significant (Table 1TI) .
De-novo adhesions are those adhesions that are found on ovaries at the time of the second-look laparoscopy, but which were absent at first-look laparoscopy. De-novo adhesions were found in four of the 16 (25%) Interceed treated ovaries, and in seven out of 12 (58%) ovaries in the control group. Although there were numerically fewer de-novo adhesions in the Interceed treated ovaries, this difference was not statistically significant (P = 0.16, Fisher's exact test).
Larger cysts required more surgical time and repair man smaller cysts. Hence, the reduction of adhesions may have been due to the distribution of large versus small cysts between the treatment groups. This possibility was examined. The size of the ovarian cysts at first surgery was analysed by categorizing the diameters into two groups: 2.5-4.5 cm and 5.0-7.0 cm. The distribution of ovarian cysts based upon initial diameter and treatment designation was as follows: for 2.5-4.5 cm: Interceed 16, control nine; and for 5.0-7.0 cm: Interceed four, control nine. The incidence of adhesion-free ovaries at secondlook based upon initial cyst size was as follows: cyst size 2.5-4.5 cm: Interceed 12 of 16 (75%), control two of nine (22%); cyst size 5.0-7.0 cm: Interceed three of four (75%), and control four of nine (44%). No significant difference was observed in the distribution of cyst diameters between the Interceed treated ovaries and the control ovaries. Therefore the beneficial effect of Interceed was not due to it being placed on smaller cysts undergoing less traumatic procedures.
It is important to note that four patients had two cysts on one of their ovaries. For purposes of cyst distribution and calculation of incidence, each cyst has been scored as though it were on a separate ovary. In one patient the two cysts were on the Interceed-treated ovary and were of different sizes. No adhesions formed on either the treated or control ovary. In the remaining three patients, cysts were of similar size. Interceed was placed on the double-cystic ovary in two patients. Adhesions formed on both Interceed and control sides in one of these patients, and on neither side in the other. In the latter patient, adhesions formed only on the double-cystic, control ovary. Of the 17 patients who returned for a second-look laparoscopy, sutures had been used on 12 Interceed-treated ovaries and 10 control ovaries during the first procedure. Table  IV compares the incidence and extent (percentage area) of adhesions at second-look laparoscopy between patients with sutured versus non-sutured ovaries. The impact of ovarian suturing upon adhesion formation was inconclusive. Of the 22 sutured ovaries, adhesions were present on 10 (45%), whereas, of the 12 non-sutured ovaries, adhesions were present on five (42%). The extent of adhesions on sutured control ovaries (20%) was numerically greater than that on non-sutured control ovaries (9%). However, this difference was not statistically significant A significant benefit was observed in the area of the ovary involved in adhesions in the Interceed treated sutured ovaries versus the control sutured ovaries (6 versus 20% respectively; P < 0.05, two tailed /-test).
No adverse events were reported by any patient in the study. Interceed placement did not cause any additional risks to patients undergoing these procedures.
Discussion
Previous reports of Interceed application via laparoscopy have been descriptive in nature and primarily addressed techniques of application (Azziz et al, 1991) and feasibility (Pados et al, 1992) . To our knowledge, this is the first clinical study investigating the efficacy of Interceed in reducing adhesion formation when the barrier was applied laparoscopically. We chose ovarian surgery as a study focus both in an effort to limit analytical problems created by variability of both anatomy and surgical techniques, as well as for the clinical significance of adhesion formation on the ovary and its common occurrence.
We found that Interceed significantly reduced the incidence of adhesion formation on the ovary after removal of ovarian cysts including endometriomas. The size of the cyst removed had no influence on the incidence of adhesion formation for either the Interceed or control ovaries.
The extent, i.e. percentage area, of adhesions on sutured ovaries appeared to be slightly greater compared with nonsutured ovaries; however, this trend was not significant Although it is well known that suturing may increase adhesion formation when the procedure is performed via laparotomy (Ellis and Heddle, 1977; Tulandi et al, 1988; Hull and Vamer, 1991; Pietrantoni et al, 1983) , presumably this is the first description of this trend from suturing performed via laparoscopy. Even when sutures were used to close the ovary, there was still a reduction in the incidence or extent of adhesions when interceed was used.
Our results confirm and extend those of others regarding the efficacy of Interceed after ovarian surgery. These recent studies (all involving laparotomy) found adhesion-free outcomes in 47 versus 25% (Franklin et al, 1995) , and 30 versus 15% (Van Geldorp, 1994) for Interceed-treated ovaries and controls, respectively. Our results of adhesion-free outcome in 75 (Interceed) and 35% (controls) are in general agreement with those found in these studies. However, further studies are still required to answer the question as to whether laparotomy and laparoscopy are quite similar in terms of formation of ovarian adhesions and their reduction by the use of Interceed.
With attention to technical details, Interceed was readily applied over the ovarian surface. Intra-peritoneal irrigants were removed prior to placing the Interceed which usually required aspiration with the patient in reverse Trendelenburg position. Interceed was introduced into the pelvis principally by back loading into the operating channel of the laparoscope. Care was taken to ensure that the channel was dry and free of blood and tissue debris before introduction of Interceed. Once in the pelvis, the barrier was mobilized with a pair of grasping J JCeckstdn et al forceps. Initially we found smaller pieces easier to use; however, with practice our facility in precise mobilization of the barrier became acceptable. We found no more than 2-3 min were required to wrap an ovary completely with Interceed, moisten it with irrigation solution, and inspect to ensure correct placement and haemostasis, as shown by Interceed not turning blacL There were no adverse experiences with the use of Interceed during laparoscopic cystectomy.
In conclusion, laparoscopic ovarian cystectomy is a safe and effective procedure for removal of endometriomas as well as serous and mucinous cysts up to 7 cm in diameter. The use of Interceed absorbable adhesion barrier was safe and effective in reducing the incidence of adhesion formation after laparoscopic ovarian cystectomy. Tulandi, T, Hum, H.S. and Gelfand, M.M. (1988) Received on June 2, 1995; accepted on December 13, 1995 
